NKGN: Total Utang marang Modal NKGen Biotech

NKGen Biotech, Inc. (NKGN) is fighting for liquidity amidst fierce competition for leadership in cell therapy. The company's price evolution on GURU.Markets shows a debt-to-equity ratio of 0.00, while patents ensure high profitability and global growth. The business relies on partnerships with specialized clinics, creating synergy to combat Alzheimer's disease through innovative treatment methods.

NKGN - Total Utang marang Modal NKGen Biotech ing rentang 21.02.2024 - 15.03.2025

Rincian metrik lan analitis perusahaan NKGen Biotech Corp (NKGN)

- rega lan prakiraan konsensus rega:
Bagan rega NKGen Biotech|NKGN - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar NKGen Biotech|NKGN - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Akuntansi saben Saham NKGen Biotech|NKGN - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku nkgenbiotech.com|NKGN - Nilai Agregat Aset
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas NKGen Biotech, Inc.|NKGN - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas NKGen Biotech, Inc.|NKGN - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku NKGen Biotech|NKGN - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan NKGen Biotech|Rasio cepet nkgenbiotech.com
- statistik bathi lan rasio pasar:
NKGN - Penghasilan resik perusahaan
Analisis umum perusahaan:NKGN, NKGen Biotech

By outsourcing production and clinical trials, NKGen Biotech, Inc. (NKGN) minimizes capital expenditures, which directly impacts its liability structure. When analyzing the leverage ratio—total debt to equity—investors assess the proportion of borrowed funds used to finance assets, where low values confirm financial stability and the absence of an excessive debt burden on the company's scientific potential.

Pesaing utama

Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|Utang marang Ekuitas Harmony Biosciences|Rasio Utang marang Ekuitas BHVN (biohavenpharma.com)|Utang marang Ekuitas Amylyx Pharmaceuticals, Inc. (AMLX)|Total Utang marang Modal Trevi Therapeutics Inc (TRVI)|Total Utang marang Modal PRAX (Praxis Medicines)|Rasio Utang marang Modal Anavex Life Sciences Corp|CeriBell, Inc. - Total Utang marang Modal|Utang marang Modal Prothena Corporation PLC|alector.com (ALEC) - Utang marang Ekuitas|Rasio Utang marang Ekuitas ANNX|Rasio Total Utang marang Ekuitas OMER|NGNE: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ACIU|Utang marang Ekuitas VYGR (voyagertherapeutics.com)|Total Utang marang Modal NMRA (Neumora Therapeutics, Inc.)|Koefisien Total Utang marang Modal Scilex Holding (SCLX)|TVGN - Utang marang Ekuitas|Utang marang Modal Alpha Cognition|CGTX (Cognition Therapeutics) - Rasio Total Utang marang Ekuitas|IKT: Utang Agregat marang Modal|SAVA (Cassava Sciences) - Total Utang marang Modal|Utang marang Modal Assertio Therapeutics ASRT|Total Utang marang Modal COYA|Rasio Total Utang marang Ekuitas vistagen.com VTGN|Total Utang marang Modal OVID (Ovid Therapeutics)|Rasio Kabeh Utang marang Dana Pribadi ABOS|CRVO: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ATHE (Alterity Therapeutics)|CLNN: Total Utang marang Modal|PEPG - Koefisien Total Utang marang Modal|Utang marang Ekuitas Jupiter Neurosciences Inc|Rasio Utang marang Ekuitas RLMD (relmada.com)|Total Utang marang Modal ANVS|Rasio Total Utang marang Ekuitas gracetx.com GRCE|Firefly Neuroscience Inc - Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal ANEW Medical (KLTO)|NRSN - Utang marang Ekuitas|RVPH (revivapharma.com) - Rasio Utang marang Ekuitas|metaviatx.com (MTVA) - Utang marang Ekuitas|NeurAxis Inc. (NRXS) - Total Utang marang Modal|HSDT (Helius Medical Technologies, Inc.) - Total Utang marang Modal|PASG - Rasio Utang marang Modal|Utang marang Ekuitas Neuphoria Therapeutics Inc. (NEUP)|minervaneurosciences.com - Rasio Utang marang Ekuitas|Utang marang Ekuitas Athira Pharma ATHA|ADXN: Rasio Utang marang Ekuitas|Alzamend - Total Utang marang Modal|Utang marang Modal Cyclerion Therapeutics|PTIX (protagenic.com) - Rasio Total Utang marang Ekuitas|Pasithea Therapeutics Corp. (KTTA) - Total Utang marang Modal|Utang marang Ekuitas Cortigent Inc|ATXI: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA - Utang marang Modal|Utang marang Ekuitas Chromocell Therapeutics CHRO|ELYM: Rasio Utang marang Ekuitas|ITCI - Utang marang Ekuitas|LBPH - Total Utang marang Modal|MRNS: Total Utang marang Modal|Rasio Utang marang Modal NeuroBo Pharma NRBO|SAGE (Sage Therapeutics, Inc.) - Total Utang marang Modal|Utang marang Modal synaptogen.com SNPX|Utang marang Ekuitas Trevena (TRVN)|vigilneuro.com - Rasio Utang marang Ekuitas|Anew Medical - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi CERE